Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The reliability of highly elevated CA 19-9 levels

B R Osswald1, F E Klee, S Wysocki

  • 1Salem Medical Center, Dept. of Medicine, Heidelberg, F.R.G.

Disease Markers
|December 1, 1993
PubMed
Summary

Extremely elevated cancer antigen 19-9 (CA 19-9) levels can occur in benign conditions, often linked to cholestasis. This study highlights that non-malignant diseases frequently explain high CA 19-9, emphasizing diverse influencing factors.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Not Available].

Zeitschrift fur Kardiologie·2014
Same author

The p53 tumor-suppressor gene is overexpressed but not mutated in human atherosclerotic tissue.

International journal of oncology·2011
Same author

Myocardial infarction: an important factor for surgical decision making?

The Thoracic and cardiovascular surgeon·2009
Same author

Minimal early mortality in CABG--simply a question of surgical quality?

The Thoracic and cardiovascular surgeon·2002
Same author

Frequent urination and Depo-Provera. Ask the experts.

Contraceptive technology update·2002
Same author

Does smoking affect efficacy of the pill? Ask the experts.

Contraceptive technology update·2002

Area of Science:

  • Gastroenterology and Hepatology
  • Clinical Biochemistry
  • Oncology Diagnostics

Background:

  • Cancer antigen 19-9 (CA 19-9) is a widely used tumor marker for upper gastrointestinal cancers.
  • Extremely elevated CA 19-9 levels are occasionally observed in patients without malignancy.
  • Understanding the causes of elevated CA 19-9 in non-malignant conditions is crucial for accurate diagnosis.

Purpose of the Study:

  • To investigate the prevalence and potential causes of extremely elevated CA 19-9 levels in patients with benign diseases.
  • To determine the association between cholestasis and high CA 19-9 levels.
  • To identify specific non-malignant conditions associated with elevated CA 19-9.

Main Methods:

  • Retrospective analysis of patient data with extremely elevated CA 19-9 levels.
  • Assessment of primary diagnoses, including malignant and benign conditions.
  • Evaluation of the presence and severity of cholestasis and other liver/biliary diseases.

Main Results:

  • Cholestasis was present in 97.1% of patients with highly elevated CA 19-9, irrespective of the underlying disease.
  • Fifty percent of patients with non-malignant diseases and elevated CA 19-9 had conditions such as liver cirrhosis, cholecystitis, pancreatitis, and/or hepatitis.
  • In 8.8% of cases, no clear explanation for the extremely high CA 19-9 level was identified.

Conclusions:

  • Elevated CA 19-9 levels, even extremely high ones, are frequently associated with cholestasis in both malignant and benign conditions.
  • Benign hepatobiliary and pancreatic diseases are significant contributors to elevated CA 19-9, necessitating careful differential diagnosis.
  • Further investigation is warranted for cases with extremely high CA 19-9 and no identifiable cause.

Related Experiment Videos